#IntoCell
LightNews LightNews
patesalo-e.bsky.social
IntoCell CEO denies patent issue as cause to scrap ABL Bio deal - koreabiomed.com: IntoCell CEO denies patent issue as cause to scrap ABL Bio deal  koreabiomed.com
IntoCell CEO denies patent issue as cause to scrap ABL Bio deal - koreabiomed.com
IntoCell CEO denies patent issue as cause to scrap ABL Bio deal  koreabiomed.com
news.google.com
August 8, 2025 at 11:43 AM
patesalo-e.bsky.social
Patent surprise ends ABL Bio’s ADC deal with IntoCell, shifts focus to Synaffix - koreabiomed.com: Patent surprise ends ABL Bio’s ADC deal with IntoCell, shifts focus to Synaffix  koreabiomed.com
Patent surprise ends ABL Bio’s ADC deal with IntoCell, shifts focus to Synaffix - koreabiomed.com
Patent surprise ends ABL Bio’s ADC deal with IntoCell, shifts focus to Synaffix  koreabiomed.com
news.google.com
July 10, 2025 at 10:06 AM
patesalo-e.bsky.social
ABL Bio returns IntoCell ADC technology amid patent disclosure concerns - CHOSUNBIZ - Chosun Biz: ABL Bio returns IntoCell ADC technology amid patent disclosure concerns - CHOSUNBIZ  Chosun Biz
ABL Bio returns IntoCell ADC technology amid patent disclosure concerns - CHOSUNBIZ - Chosun Biz
ABL Bio returns IntoCell ADC technology amid patent disclosure concerns - CHOSUNBIZ  Chosun Biz
news.google.com
July 10, 2025 at 7:01 AM
patesalo-e.bsky.social
ABL Bio terminates contract with IntoCell over ADC patent uncertainties - CHOSUNBIZ - Chosunbiz: ABL Bio terminates contract with IntoCell over ADC patent uncertainties - CHOSUNBIZ  Chosunbiz
ABL Bio terminates contract with IntoCell over ADC patent uncertainties - CHOSUNBIZ - Chosunbiz
ABL Bio terminates contract with IntoCell over ADC patent uncertainties - CHOSUNBIZ  Chosunbiz
news.google.com
July 9, 2025 at 9:01 AM
newsen.bsky.social
Piramal Pharma Solutions Strengthens Bioconjugate Capabilities with IntoCell Partnership#India#Mumbai#Piramal_Pharma#bioconjugates#IntoCell
Piramal Pharma Solutions Strengthens Bioconjugate Capabilities with IntoCell Partnership
Piramal Pharma Solutions collaborates with IntoCell to enhance its bioconjugate offerings and advance innovative drug technologies, particularly ADCs.
third-news.com
October 30, 2025 at 11:11 PM
newsen.bsky.social
Piramal Pharma and IntoCell Join Forces to Enhance Bioconjugate Platforms and Capabilities#India#Mumbai#ADC_Development#Piramal_Pharma#IntoCell
Piramal Pharma and IntoCell Join Forces to Enhance Bioconjugate Platforms and Capabilities
Piramal Pharma Solutions has announced a strategic partnership with IntoCell to expand its bioconjugate capabilities, leveraging innovative payload-linker technologies.
third-news.com
October 30, 2025 at 10:59 PM
newsen.bsky.social
Piramal Pharma Solutions and IntoCell Unite to Enhance Bioconjugate Technologies#India#Mumbai#Piramal_Pharma#ADC_Technologies#IntoCell
Piramal Pharma Solutions and IntoCell Unite to Enhance Bioconjugate Technologies
Piramal Pharma Solutions partners with IntoCell to expand bioconjugate capabilities, leveraging advanced drug-linker technologies to boost innovation.
third-news.com
October 30, 2025 at 5:34 AM
newsen.bsky.social
Piramal Pharma Solutions Partners with IntoCell for Enhanced Bioconjugate Technology#India#Mumbai#ADC_Development#Piramal_Pharma_Solutions#IntoCell
Piramal Pharma Solutions Partners with IntoCell for Enhanced Bioconjugate Technology
Piramal Pharma Solutions has established a partnership with IntoCell to enhance its bioconjugate capabilities and expedite drug development efforts.
third-news.com
October 30, 2025 at 5:26 AM
l2plabs.bsky.social
Piramal Pharma Solutions officialise son partenariat avec IntoCell, élargissant ainsi sa plateforme de payload-linker et ses capacités en matière de bioconjugués
Piramal Pharma Solutions s'est associé à IntoCell pour enrichir son portefeuille de bioconjugués et soutenir l'innovation dans ce domaine. En s'appuyant sur les technologies propriétaires d'IntoCell en matière de liaison médicamenteuse et sur sa formidable expérience de 20 ans dans le...
dlvr.it
October 30, 2025 at 11:01 PM